Zymeworks to Present at Ladenburg Thalmann Healthcare Conference
July 08 2021 - 08:30AM
Business Wire
Zymeworks Inc. (NYSE: ZYME), a clinical-stage biopharmaceutical
company developing multifunctional biotherapeutics, today announced
that the Company will present at the upcoming Ladenburg Thalmann
Healthcare Conference on July 14, 2021 at 4:00 p.m. ET. The
presentation will be webcast live and available for replay on
Zymeworks’ website at
http://ir.zymeworks.com/events-and-presentations.
About Zymeworks Inc.
Zymeworks is a clinical-stage biopharmaceutical company
dedicated to the development of next-generation multifunctional
biotherapeutics. Zymeworks’ suite of therapeutic platforms and its
fully integrated drug development engine enable precise engineering
of highly differentiated product candidates. Zymeworks’ lead
product candidate, zanidatamab (ZW25), is a novel Azymetric™
bispecific antibody which has been granted Breakthrough Therapy
designation by the FDA and is currently enrolling in a pivotal
clinical trial for refractory HER2-amplified biliary tract cancer
(HERIZON-BTC-01) as well as several Phase 2 clinical trials for
HER2-expressing gastroesophageal and breast cancers. Zymeworks’
second product candidate, ZW49, is a bispecific antibody-drug
conjugate currently in Phase 1 clinical development and combines
the unique design and antibody framework of zanidatamab with
Zymeworks’ proprietary ZymeLink™ linker-cytotoxin. Zymeworks is
also advancing a deep preclinical pipeline in oncology (including
immuno-oncology agents) and other therapeutic areas. In addition,
its therapeutic platforms are being leveraged through strategic
partnerships with nine biopharmaceutical companies. For additional
information about Zymeworks, visit www.zymeworks.com and follow
@ZymeworksInc on Twitter.
View source
version on businesswire.com: https://www.businesswire.com/news/home/20210708005209/en/
Investor Inquiries: Ryan Dercho, Ph.D. (604) 678-1388
ir@zymeworks.com
Jack Spinks (604) 678-1388 ir@zymeworks.com
Media Inquiries: Mary Klem (604) 678-1388
media@zymeworks.com
Zymeworks (NYSE:ZYME)
Historical Stock Chart
From Feb 2024 to Mar 2024
Zymeworks (NYSE:ZYME)
Historical Stock Chart
From Mar 2023 to Mar 2024